The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
White Papers
This white paper explores the realities facing healthcare delivery, some of the new models being developed and what they could mean for the s
Letter/Comment
An announcement of the Final Rule issued by the IRS.
Issue Brief
The Medical Device Excise Tax, a component of the Affordable Care Act, is approaching implementation at the beginning of 2013.
Toolkits/Methodology
How-to guide to managing IV disruptions.
Advisory
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.
The AHRMM Cost, Quality, and Outcomes (CQO) Movement frames the critical role supply chain professionals play in driving high quality care, at a more…